Status:
COMPLETED
Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke
Lead Sponsor:
Dongguan People's Hospital
Conditions:
Cognitive Impairment
Stroke
Eligibility:
All Genders
40-80 years
Brief Summary
This registration enrolled patients with acute ischemic stroke within 72 hours after stroke ictus. Patients was identified as first-ever stroke based on past medical histrory. Admission CT was conduct...
Detailed Description
This is a perspective stroke registry cohort study. Stroke patients were included if ：(1) acute first-ever ischemic stroke and admitted within 72 hours after onset; (2) clinical stroke diagnosis was c...
Eligibility Criteria
Inclusion
- acute first-ever ischemic stroke and admitted within 72 hours after onset;
- clinical stroke diagnosis was confirmed with positive diffusion-weighted magnetic resonance imaging (DW-MRI), those with isolated posterior circulations infarcts were exclude ;
- presented with mild stroke severity ( admission NIHSS score ≤5);
- age between 40 and 80 years.
Exclusion
- Patients with index cognitive impairment or under current anti-dementia or psychiatric medication;
- patients with large infarcts (≥1/3 middle cerebral artery territory);
- patients with severe language or physical disability that impede neuropsychological testing;
- patients with recurrent transient ischemic attack (TIA)/stroke during follow-up;
- coexisting serious conditions known to impair cognitive function
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2018
Estimated Enrollment :
435 Patients enrolled
Trial Details
Trial ID
NCT04135872
Start Date
January 1 2017
End Date
August 30 2018
Last Update
October 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguan Peoples' Hospital
Dongguan, Guangdong, China, 523029